Skip to main content
OpenTrials
Completed

NCT Number: NCT02760303

Reducing Stress in Adolescents and Young Adults With Type 1 Diabetes to Improve Diabetes Care

Adolescence and young adulthood may be particularly stressful developmental periods due to the numerous transitions into new roles and the need for increased independence. Stress can affect metabolic control in older adolescents and young adults with T1D directly through its impact on cortisol and other hormones that affect insulin metabolism.

The proposed study is a pilot randomized clinical trial using a three-group randomized, repeated measures design to assess the efficacy of two treatments (Mindfulness Based Stress Reduction (MBSR) and Cognitive Behavioral Therapy or (CBT) versus an attention control condition for older adolescents and young adults with poorly controlled Type 1 diabetes. As a pilot study, the goal of the research is to test recruitment and retention procedures, finalize intervention measures, training, and fidelity protocols, and estimate effect sizes for a larger clinical trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–20 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Wayne State University School of Medicine

Detroit, Michigan, 48202, United States

About this study

This study will use a randomized, repeated measures design. A sample of 125 participants will be recruited and consented from the Children's Hospital of Michigan and outpatient diabetes clinics affiliated with the Detroit Medical Center. 108 will be randomized to one of three treatment conditions (remaining participants are expected to consent but not enroll or fail to initiate treatment). These participants will be enrolled in 3 cohorts of 30-36 participants.

Measures will be administered at 3 home-based study visits to maximize participant convenience. The initial study visit (Visit 1) will be scheduled at the beginning of the study. Visit 2 will coincide with the end of treatment which is approximately 3 months after the initial study visit. Visit 3 is the 3-month follow up and will be scheduled about 6 months after the initial study visit. At each visit, participants will complete questionnaires assessing their current diabetes management, stressors, quality of life, mental health, and demographic characteristics. These questionnaires will be completed using Qualtrics accessed via the internet on a university laptop computer. A research assistant will download the participant's glucose meter to obtain the frequency of blood glucose testing during the two weeks preceding data collection. The research assistant will also assist participants with providing a blood sample via fingerstick (HbA1c) and saliva samples by mouth (cortisol, Visits 1 and 2 only). All participants will be asked to take part in an exit interview at Visit 3 to obtain feedback on the treatment they received.

After Visit 1, participants will be randomized using a 1:1:1 ratio to MBSR, CBT, or Diabetes Support and Education (DSE). All three treatments are group format meeting (10-12 participants per group) for nine consecutive weeks at a location convenient to the participants. In MBSR treatment focuses on the instruction and practice of mindfulness techniques, such as meditation and yoga, and the application of these practices to everyday activities. CBT utilizes activities to understand how thoughts affect emotions and behaviors, the application of these activities to current stressors, and strategies to apply these new skills to future stressors. The DSE group is the attention control condition; DSE participants will receive diabetes education via a support group format. All group sessions will be audiotaped for treatment fidelity monitoring and assessment. There are no planned research interventions for the DSE group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 16 years, 0 months to 20 years, 11 months
  • Diagnosed with type 1 diabetes for at least six months
  • Poor metabolic control as defined by HbA1c >=9%

Exclusion criteria

  • Mental health conditions that might compromise data integrity (e.g., developmental delay, psychosis, suicidality)
  • Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis)
  • Inability to speak or read English

Treatment and study plan

Cognitive behavioral therapy

Behavioral

Participants will attend group therapy sessions, once a week for 9 weeks. The focus of these sessions will be the thought-emotion-behavior linkages as outlined by cognitive-behavioral theory. Activities will illustrate how thoughts affect emotions and behaviors, the application of these activities to current stressors, and strategies to apply these new skills to future stressors.

Other names: CBT

Mindfulness Based Stress Reduction

Behavioral

Participants will attend group therapy sessions, once a week for 9 weeks. The focus of these sessions will be understanding how to gain control over one's thoughts and feelings using relaxation, meditation, and other mindfulness-based techniques. Activities will focus on the instruction and practice of mindfulness techniques, such as meditation and yoga, and the application of these practices to everyday activities.

Other names: MBSR

Diabetes Support and Education

Behavioral

Participants will attend group therapy sessions, once a week for 9 weeks. Participants will receive diabetes education via a support group format. The focus of these sessions will be peer group social support and non-adherence diabetes education topics (e.g., emergency preparedness, smoking and diabetes).

Other names: DSE

Primary outcomes

  1. Metabolic Control

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Hemoglobin A1c (HbA1c)

Secondary outcomes

  1. Regimen Adherence (objective)

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Frequency of Glucose Meter Testing

  2. Regimen Adherence (daily diary)

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    24 Hour Recall of Diabetes Adherence Behavior

  3. Regimen Adherence (self-reported)

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Diabetes Management Scale (DMS)

  4. Psychological Stress (general)

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Perceived Stress Scale (PSS)

  5. Psychological Stress (diabetes-related)

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Diabetes Stress Questionnaire (DSQ)

  6. Psychological Stress (attitudes)

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Hassles and Uplifts Scale

  7. Diabetes Quality of Life

    Time frame: Change from Baseline at 3 months, Change from Baseline at 6 months

    Diabetes Quality of Life Scale

Sponsors and collaborators

Lead sponsor

Wayne State University

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

Reducing Stress in Adolescents and Young Adults With T1D to Improve Diabetes Care

Acronym: T1D

Important dates

Study start
2015
Primary completion
2016
Study completion
2017
First posted
May 3, 2016
Registry last updated
Jun 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.